MYX 0.20% $5.09 mayne pharma group limited

News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    May 14 (Reuters) - Mayne Pharma Group Ltd (MYX) :

    • EXPECTS 4QFY19 TO BE STRONGER DRIVEN BY REBOUND IN GENERIC PRODUCTS
    • JAN-APRIL REPORTED REVENUE $154.1 MILLION, DOWN 15%
    • JAN-APRIL GENERIC PRODUCTS $88.9 MILLION, DOWN 32%
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$5.09
Change
-0.010(0.20%)
Mkt cap ! $422.8M
Open High Low Value Volume
$5.10 $5.15 $4.91 $534.8K 105.9K

Buyers (Bids)

No. Vol. Price($)
3 747 $5.09
 

Sellers (Offers)

Price($) Vol. No.
$5.11 29 1
View Market Depth
Last trade - 12.27pm 11/11/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.